2025 second_quarter Filing
Q2Lobbying Activities
Issues relating to drug pricing policy. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act.
Intellectual property protections and enforcement. Biopharmaceutical patent policy.